The grand challenges and potential of AI-driven insights in drug development and the impact of recent FDA guidance
Join IDBS, Danaher strategy leaders and other industry leaders for an invitation-only evening round table discussion over dinner
May 16th, 2023 | 7:30pm ET
Join IDBS at The Capital Grille, Boston’s premier destination for fine dining and wine at the Hynes Convention Center, conveniently co-located with PEGS Boston and BioIT World conferences for a round table discussion on:
The grand challenges and potential of AI-driven insights in drug development and the impact of recent FDA guidance.
Discussion topics will include:
- The Danaher strategic partnership with the University of Pennsylvania (Penn) and the role of data science in cell therapy innovation
- Implications of the FDA patient-focused drug development guidance
- What role will data play in how the FDA Modernization Act 2.0 changes pre-clinical R&D?
- Capitalizing on AI – what skillsets and structures are needed to ask the right questions and ensure success?
This is an invitation-only event and places are extremely limited so please complete the registration form only if you have received a direct invitation from an IDBS representative.
Please do not forward the link to this page to your colleagues. The IDBS representative you are in contact with will be happy to extend further invitations to your colleagues should there be places left.
After your registration has been confirmed we will be in contact with further information, including a calendar blocker and a survey to collect your dietary requirements.